Association of pSTAT3, pSyk with c-Myc, p53, BCL2 proteins expression and survival of patients with diffuse large B-cell lymphoma
Background. Diffuse large B cell lymphoma (DLBCL) is one of the most common non-Hodgkin’s lymphomas. The effectiveness of R-CHOP (rituximab, cyclophosphamide, hydroxydaunorubicin, oncovin, prednisone) therapy was observed in about 60 % of patients, in 20–30 % of cases DLBCL is characterized by a ref...
Main Authors: | V. A. Rosin, E. V. Vaneeva, D. A. Dyakonov, S. V. Samarina, I. V. Paramonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-04-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/540 |
Similar Items
-
PROGNOSTIC VALUE OF pSTAT3 EXPRESSION IN DIFFUSIVE B-LARGE CELL LYMPHOMA IN THE RUSSIAN PATIENT SAMPLE
by: E. V. Vaneeva, et al.
Published: (2019-11-01) -
Silibinin plus Stupp protocol as conversion therapy for unresectable glioblastoma with pSTAT3 expression, an oasis in the desert? A case report description.
by: Valeria Internò, et al.
Published: (2023-03-01) -
Potential Refinement of Recurrence Score by pSTAT3 Status
by: Albert Grinshpun, et al.
Published: (2022-02-01) -
Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer
by: Esmeralda C. Marginean, et al.
Published: (2021-02-01) -
NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
by: Qiao Zhang, et al.
Published: (2020-10-01)